This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Social Bookmarking   What's this?

Andrew A. Skolnick

JAMA. 1998;280:683-684.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A CANADIAN appeals court has upheld a lower court's decision denying a pharmaceutical company's motion to block publication of a health technology report that the company contends may damage its commercial interests.

In December 1997, Bristol-Myers Squibb Canada Inc sued the Canadian Coordinating Office of Health Technology Assessment (CCOHTA) to prevent the release of its summary report on cholesterol-lowering statin drugs. The company contends that the report contains "negligent misstatements" that could negatively affect the sale of its drug Pravachol (pravastatin).

When the Ontario Court denied Bristol-Myers Squibb's motion for an injunction to suppress the report in March, the company appealed. On May 6, an appeals court upheld the lower court's decision and CCOHTA promptly published the report, A Clinical and Economic Review of HMG-CoA Reducatase Inhibitors in Coronary Heart Disease, which was based on a technical review of published clinical trials and pharmacoeconomic evaluations. "However, . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Paroxetine Treatment of Generalized Social Phobia (Social Anxiety Disorder): A Randomized Controlled Trial
Murray B. Stein, Michael R. Liebowitz, R. Bruce Lydiard, Cornelius D. Pitts, William Bushnell, and Ivan Gergel
JAMA. 1998;280(8):708-713.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Getting it right: industry sponsorship and medical research
Baird
CMAJ 2003;168:1267-1269.
FULL TEXT  

Dancing with the porcupine: rules for governing the university-industry relationship
Lewis et al.
CMAJ 2001;165:783-785.
FULL TEXT  

Users' Guides to the Medical Literature: XIX. Applying Clinical Trial Results; B. Guidelines for Determining Whether a Drug Is Exerting (More Than) a Class Effect
McAlister et al.
JAMA 1999;282:1371-1377.
FULL TEXT